Peer-Reviewed Journal Details
Mandatory Fields
Rodes-Cabau, Josep and Facta, Alvaro and Larose, Eric and DeLarochelliere, Robert and Dery, Jean-Pierre and Nguyen, Can Manh and Roy, Louis and Proulx, Guy and Gleeton, Onil and Barbeau, Gerald and Noel, Bernard and Rouleau, Jacques and Boudreault, Jean-Roch and Bertrand, Olivier F.;
2007
American Journal of Cardiology
Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting
Validated
()
Optional Fields
100
4
640
645
The objective of this study was to evaluate the clinical and angiographic factors associated with significant saphenous vein graft (SVG) atherosclerosis progression at mid-term follow-up in a series of unselected coronary patients who had previously received a coronary artery bypass graft (CABG). A total of 123 SVGs from 86 patients who underwent cardiac catheterization twice, 15 +/- 12 months apart, were included in the study. None of the SVGs presented any >=50\% diameter Aenosis (DS) lesion or underwent any intervention at baseline. All SVGs were divided into 3 segments and each SVG segment was scored from 0 to 3 depending on the presence of lesions, with percent DS ranging from 0\% to 19\% (score 0), 20\% to 29\% (score 1), 30\% to 39\% (score 2), and >=40\% (score 3). The SVG atherosclerotic burden score (ABS) was calculated by adding the score obtained for each of the 3 SVG segments. Significant progression was defined as >=10\% increase in lesion percent DS or >=0.6 mm decrease in minimal lumen diameter between baseline and follow-lip studies. Mean age of the study population was 66 9 years, and most of the patients were receiving statin therapy with mean low-density lipoprotein cholesterol of 85 +/- 26 mg/dl. Significant angiographic progression occurred in >=1 SVG in 41 patients (48\%). On multivariate analysis, the variables associated with SVG atherosclerosis progression were SVG ABS (odds ratio [OR], 1.52 for each increase of 1 point in SVG ABS; 95\% confidence interval [CI] 1.1 to 2.29) and high-density lipoprotein (HDL) cholesterol (OR 1.38 for each decrease of 5 mg/dl in HDL cholesterol levels, 95\% CI 1.09 to 1.85). Twenty-two patients (26\%) had a cardiac event at follow-up related to SVG disease progression. The percent DS of the SVG segment at baseline was associated with SVG disease progression leading to a cardiac event (OR 3.67 for each increase of 5\% in percent DS, 95\% CI 2.11 to 6.38). In conclusion, simple clinical and angiographic variables such as HDL cholesterol, ABS, and lesion severity remain independent predictors of significant SVG atherosclerosis progression in mild to moderately diseased SVGs despite mean low-density lipoprotein levels < 90 mg/dl. (c) 2007 Elsevier Inc. All rights reserved.
10.1016/j.amjcard.2007.03.080
Grant Details